title: High-performance liquid chromatography methods for the separation and quantitation of spironolactone and its degradation products in aqueous formulations and of its metabolites in rat serum.
abstract: HPLC assays have been developed for the determination of spironolactone and its degradation products 7 alpha-thiospirolactone and canrenone in aqueous solutions of beta-cyclodextrins and for the determination of spironolactone and its metabolites 7 alpha-thiospirolactone, 7 alpha-thiomethylspirolactone, 6 beta-hydroxy-7 alpha-thiomethylspirolactone and canrenone in rat serum samples. Both methods were well suited for their respective applications, i.e., studying the stability of spironolactone in liquid formulations of beta-cyclodextrins and the oral absorption of spironolactone in rats. The HPLC method developed for spironolactone and its metabolites in rat serum requires very small volumes of serum making it possible to take several blood samples over a period of time.
authors.affiliation: Department of Pharmacy, University of Helsinki, Finland.
authors.forename: A M
authors.initials: AM
authors.lastname: Kaukonen
authors.forename: P
authors.initials: P
authors.lastname: Vuorela
authors.forename: H
authors.initials: H
authors.lastname: Vuorela
authors.forename: J P
authors.initials: JP
authors.lastname: Mannermaa
mesh_terms: D000818:Animals; D001711:Biotransformation; D002138:Calibration; D002851:Chromatography, High Pressure Liquid; D008297:Male; D000451:Mineralocorticoid Receptor Antagonists / Q000097:blood* / Q000493:pharmacokinetics; D051381:Rats; D017208:Rats, Wistar; D015203:Reproducibility of Results; D013148:Spironolactone / Q000097:blood* / Q000493:pharmacokinetics
chemical_list: D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone